KPIs & Operating Metrics(New)
Assets By SegmentBreakdown Of AssetsCapital Expenditure By SegmentCost Of Goods And Services SoldDeferred IncomeDepreciation And Amortization By SegmentEmployee StatisticsGross Margin %Gross Margin By Segment %Gross Margin By Segment Annual %Gross ProfitGross Profit By SegmentGross Profit By Segment AnnualIncome Before Income TaxLong Lived Assets By GeographyNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Lease LiabilitiesOperating Margin By Segment %Operating Profit By SegmentOpex As A % Of Total Revenue %OPEX SegregationProperty, Plant And Equipment, Net BreakdownRevenue By Country AnnualRevenue By Country Annual %Revenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By Market GroupRevenue By Market Group %Revenue By Market Group AnnualRevenue By Market Group Annual %Revenue By Product CategoryRevenue By Product Category %Revenue By Product Category AnnualRevenue By Product Category Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Gross Profit (2016 - 2025)

Historic Gross Profit for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $294.3 million.

  • West Pharmaceutical Services' Gross Profit rose 1118.25% to $294.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 703.82%. This contributed to the annual value of $998.5 million for FY2024, which is 1157.46% down from last year.
  • According to the latest figures from Q3 2025, West Pharmaceutical Services' Gross Profit is $294.3 million, which was up 1118.25% from $273.9 million recorded in Q2 2025.
  • West Pharmaceutical Services' Gross Profit's 5-year high stood at $321.5 million during Q2 2022, with a 5-year trough of $230.0 million in Q2 2024.
  • Over the past 5 years, West Pharmaceutical Services' median Gross Profit value was $273.9 million (recorded in 2025), while the average stood at $275.8 million.
  • As far as peak fluctuations go, West Pharmaceutical Services' Gross Profit skyrocketed by 6281.44% in 2021, and later plummeted by 2107.07% in 2024.
  • Over the past 5 years, West Pharmaceutical Services' Gross Profit (Quarter) stood at $300.6 million in 2021, then decreased by 12.81% to $262.1 million in 2022, then rose by 6.14% to $278.2 million in 2023, then decreased by 1.65% to $273.6 million in 2024, then grew by 7.57% to $294.3 million in 2025.
  • Its Gross Profit was $294.3 million in Q3 2025, compared to $273.9 million in Q2 2025 and $231.9 million in Q1 2025.